Source:http://linkedlifedata.com/resource/pubmed/id/15564581
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
47
|
pubmed:dateCreated |
2004-11-26
|
pubmed:abstractText |
Typically, D1 and D2 dopamine (DA) receptors exert opposing actions on intracellular signaling molecules and often have disparate physiological effects; however, the factors determining preferential activation of D1 versus D2 signaling are not clear. Here, in vitro patch-clamp recordings show that DA concentration is a critical determinant of D1 versus D2 signaling in prefrontal cortex (PFC). Low DA concentrations (<500 nm) enhance IPSCs via D1 receptors, protein kinase A, and cAMP. Higher DA concentrations (>1 microm) decrease IPSCs via the following cascade: D2-->G(i)-->platelet-derived growth factor receptor--> increase phospholipase C--> increase IP3--> increase Ca2+--> decrease dopamine and cAMP-regulated phosphoprotein-32--> increase protein phosphatase 1/2A--> decrease GABA(A). Blockade of any molecule in the D2-linked pathway reveals a D1-mediated increase in IPSCs, suggesting that D1 effects are occluded at higher DA concentrations by this D2-mediated pathway. Thus, DA concentration, by acting through separate signaling cascades, may determine the relative amount of cortical inhibition and thereby differentially regulate the tuning of cortical networks.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP-Dependent Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D2,
http://linkedlifedata.com/resource/pubmed/chemical/gamma-Aminobutyric Acid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1529-2401
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
24
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
10652-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15564581-Animals,
pubmed-meshheading:15564581-Cyclic AMP-Dependent Protein Kinases,
pubmed-meshheading:15564581-Dopamine,
pubmed-meshheading:15564581-Dose-Response Relationship, Drug,
pubmed-meshheading:15564581-Electrophysiology,
pubmed-meshheading:15564581-Mice,
pubmed-meshheading:15564581-Mice, Inbred C57BL,
pubmed-meshheading:15564581-Neural Inhibition,
pubmed-meshheading:15564581-Patch-Clamp Techniques,
pubmed-meshheading:15564581-Prefrontal Cortex,
pubmed-meshheading:15564581-Pyramidal Cells,
pubmed-meshheading:15564581-Rats,
pubmed-meshheading:15564581-Rats, Sprague-Dawley,
pubmed-meshheading:15564581-Receptors, Dopamine D1,
pubmed-meshheading:15564581-Receptors, Dopamine D2,
pubmed-meshheading:15564581-Signal Transduction,
pubmed-meshheading:15564581-gamma-Aminobutyric Acid
|
pubmed:year |
2004
|
pubmed:articleTitle |
Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex.
|
pubmed:affiliation |
Physiology and Neuroscience Department, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
In Vitro,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|